HIV Vaccine Phase 1 Trial Begins in the US and South Africa
National Institutes of Health
Novel vaccine uses weakened cytomegalovirus as a vector to deliver and alert the immune system
HIV Research
New Drug Formulation Could Improve HIV Treatment in Children
University of Colorado Anschutz Medical Campus
Research confirms the safety and effectiveness of the first child-friendly single fixed-dose combination HIV treatment
Tackling HIV Drug Resistance Using Novel Candidates
Salk Institute
Research could lead to the development of new HIV therapeutics that overcome resistance to existing drugs
Protein Driving HIV Latency as a New Therapeutic Target
University of Montreal Hospital Research Centre
AhR protein allows HIV to evade the immune system and, hence, may prove to be a good therapeutic target
FDA Proposes New Blood Donor Assessment Model
Swathi Kodaikal, MSc
Most LGBTQ+ advocates welcome FDA’s proposed blood donor eligibility guidance, despite its flaws
FDA Approves New HIV Drug for Adults with Limited Treatment Options
U.S. Food and Drug Administration
The new medication is for those whose HIV infections cannot be successfully treated with other treatments
Encouraging Findings in First-in-Human Clinical Trial Evaluating HIV Vaccine
The Scripps Research Institute
Scripps Research publish study data in Science, helping validate novel vaccination strategy
COVID-19 Disruptions in HIV Testing, Prevention Highlight Need for Innovation
Centers for Disease Control and Prevention
The rapid rebound in services, if scaled up, could help reach national prevention goals
A Better Understanding of How HIV-1 Evades the Immune System
University of Montreal
The expression of Vpu helps infected cells evade the ADCC elimination method
Early HIV Diagnosis and Treatment Important for Better Health Outcomes
National Institutes of Health
Findings based on an extended follow-up of participants in the START study